August 21: Capital Is the New Compute — The AI Trade Meets a Financing Wall

Market regime

The Goldilocks spine holds — sticky CPI 2.72% and falling, unemployment 4.1%, a bull-steepened 10Y-2Y at +51bp, VIX 14.6 — but the market's center of gravity has shifted from what to own to who can keep paying for it. Breadth on the 8/19 tape was strong (2,990 up vs 1,635 down, +0.78% average), yet the leadership split in two directions at once: hard assets and cure-catalysts ripped higher while the AI-hardware complex cracked. That divergence is the story. This is no longer one rotation; it is the market re-pricing the cost of capital into the most debt-hungry corner of the economy.

Mega forces

1. The financing bottleneck. BlackRock's strategist has been flagging it all month: aggregate capex is now running at operating-cash-flow, and the marginal dollar of AI expansion is being funded with debt, not retained earnings. Broadcom's reported $100B financing package — with Blackstone and Apollo in the loop and Anthropic consuming 40%+ of its AI-chip revenue — is the emblem. Hyperscaler borrowing, off-balance-sheet chip financing, and a still-elevated Treasury issuance calendar are all competing for the same capital. When the long end stays pinned near multi-decade highs, the cheapest part of the AI complex (the hardware that needs to be financed) reprices first.

2. The AI supply chain fragments to challengers. Google's expanded Marvell agreement (a warrant for up to $12.2B of stock) pits a challenger against Broadcom, and the tape responded instantly: MRVL +9.8%, AVGO -4.6%, while semi-cap equipment (LRCX, KLAC) and memory (STX -7.9%, WDC -6.9%) led the declines. Concentration risk is being priced out of the hyper-concentrated winners. The compute monopoly premium is leaking toward the attach-and-interconnect layer.

3. Hard money beats crypto as the debasement hedge. Treasury's doubling of long-dated buybacks is pushing yields and the dollar lower, and capital is choosing the real dollar hedge: gold and silver miners led all themes (+23% on the month), while bitcoin mining (-19.5%), XRP (-7.7%) and crypto ETFs unwound. In a soft-dollar regime, history's store of value — not the synthetic one — is getting the bid.

4. The international handoff. The broad dollar is down 2.3% over a month, and equities are voting with it: Germany +8.9%, France +5.2%, UK +4.8%, Japan +4.5% all ahead of the S&P's +3.7%. Japan's steepened curve and a still-yen-hedged JGB yield pickup over Treasuries make this more than a momentum trade.

What's working

• Precious metals & miners (GDX, GDXJ, SIL, SLVR): the cleanest expression of the Treasury-buyback/soft-dollar force.
• Biotech & precision medicine: the Moderna/Merck Phase 3 melanoma win (MRNA +177%) validated a first-in-class mRNA cancer platform and lifted the whole drug-discovery theme (+18% on the month) — a catalyst, not just a factor.
• International equities, especially Europe and Japan, on dollar weakness and a steeper JGB curve.
• Enterprise software & business services (NOW +6.5%, CRM +5.1%, ACN +5.9%) riding broad earnings strength across all sectors.

What to avoid

• AI hardware and memory: semi-cap equipment (-8.9% theme), memory chips, and the financing-dependent AI infrastructure names are absorbing the cost-of-capital repricing.
• Crypto-adjacent equity (miners, XRP vehicles): fighting both a rising-yield regime and the rotation into gold.
• Defensive bond-proxies (Utilities -7.4%): no longer needed as ballast while risk appetite is broadening.

Strategy

The tactical message is that leadership has broadened, not broken. The equal-weight S&P has been beating the cap-weighted index precisely because earnings are strong almost everywhere while AI's most-levered names digest a financing reality check. Favor the laggards of the AI plumbing (attach/interconnect over pure compute), the hard-asset inflation hedges, and the un-crowded international sleeve — while treating the concentration-trade unwind in semis as a buying opportunity only once the financing overhang clears.